Subscribe: NIDA | Open Studies | updated in the last 30 days
Preview: NIDA | Open Studies | updated in the last 30 days NIDA | Recruiting, Not yet recruiting, Available Studies | Last update posted in the last 30 days

Studies found on by a search of: NIDA | Recruiting, Not yet recruiting, Available Studies | Last update posted in the last 30 days

Published: Wed, 25 Apr 2018 09:21:51 EDT


Feasibility and Validation of a Standard Phenotyping Assessment Battery

Thu, 12 Apr 2018 12:00:00 EDT

Conditions:   Opioid-use Disorder;   Cocaine Use Disorder
Sponsors:   Virginia Commonwealth University;   National Institute on Drug Abuse (NIDA)
Not yet recruiting

Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use

Wed, 18 Apr 2018 12:00:00 EDT

Conditions:   Substance Abuse, Intravenous;   Prevention and Control
Intervention:   Behavioral: Break the Cycle Intervention
Sponsors:   Icahn School of Medicine at Mount Sinai;   University of Tartu;   National Institute on Drug Abuse (NIDA)

Social Media HIV Prevention Intervention for High Risk Rural Women

Wed, 07 Mar 2018 12:00:00 EST

Condition:   HIV/AIDS
Intervention:   Behavioral: NIDA Standard for HIV Prevention
Sponsors:   University of Kentucky;   National Institute on Drug Abuse (NIDA)
Not yet recruiting

The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products

Tue, 10 Apr 2018 12:00:00 EDT

Condition:   Nicotine Dependence, Cigarettes
Interventions:   Drug: Nicotine patch;   Other: Placebo patch;   Other: E-cigarettes;   Other: Non-nicotine e-cigarettes
Sponsors:   Duke University;   National Institute on Drug Abuse (NIDA)
Not yet recruiting

Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color

Thu, 05 Apr 2018 12:00:00 EDT

Conditions:   Substance Use;   Sexual Risk
Interventions:   Behavioral: YMHP Intervention;   Behavioral: Enhanced Treatment as Usual
Sponsors:   Hunter College of City University of New York;   National Institute on Drug Abuse (NIDA)

Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]

Thu, 29 Mar 2018 12:00:00 EDT

Condition:   Hepatitis C, Chronic
Interventions:   Drug: Sofosbuvir;   Drug: Daclatasvir;   Drug: Pegylated Interferon alfa-2a
Sponsors:   Johns Hopkins Bloomberg School of Public Health;   National Institute on Drug Abuse (NIDA);   YR Gaitonde Centre for AIDS Research and Education

The Effect of Andrographis Paniculata to GLP-1, Fasting Insulin, Insulin 2-h Post OGTT, and HOMA-IR

Tue, 06 Mar 2018 12:00:00 EST

Condition:   Increased Insulin
Intervention:   Other: Andrographis Paniculata Ext
Sponsor:   Indonesia University

Imaging Biomarker for Addiction Treatment Outcome

Fri, 09 Feb 2018 12:00:00 EST

Conditions:   Opioid-Related Disorders;   Alcohol-Related Disorders
Sponsor:   National Institute on Drug Abuse (NIDA)
Not yet recruiting

Cariprazine Effects on Brain and Behavior in Cocaine Use Disorder

Tue, 13 Feb 2018 12:00:00 EST

Condition:   Cocaine Use Disorder
Interventions:   Drug: Cariprazine Oral Capsule [Vraylar];   Drug: Placebo oral capsule
Sponsors:   Anna Rose Childress;   National Institute on Drug Abuse (NIDA)

Mechanism of Non-invasive Magnetic Stimulation

Tue, 09 Jan 2018 12:00:00 EST

Condition:   Healthy Volunteers
Intervention:   Device: TMS
Sponsor:   National Institute on Drug Abuse (NIDA)
Not yet recruiting

Effects of Smoking Environments on Brain Reactivity

Mon, 05 Feb 2018 12:00:00 EST

Condition:   Cigarette Smoking
Intervention:   Drug: Nicotine patch
Sponsors:   Duke University;   National Institutes of Health (NIH);   National Institute on Drug Abuse (NIDA)

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Tue, 23 Jan 2018 12:00:00 EST

Condition:   Opioid-use Disorder
Intervention:   Other: PROUD Intervention
Sponsors:   Kaiser Permanente;   National Institute on Drug Abuse (NIDA);   The EMMES Corporation

A Trial of Directly Observed and Long-term Varenicline

Thu, 07 Dec 2017 12:00:00 EST

Conditions:   Tobacco Use Disorder;   Opioid-use Disorder
Interventions:   Drug: Long-Term Varenicline;   Drug: Short-Term Varenicline;   Behavioral: Directly Observed Therapy;   Behavioral: Self Administered Therapy
Sponsors:   Albert Einstein College of Medicine, Inc.;   National Institutes of Health (NIH);   Pfizer;   National Institute on Drug Abuse (NIDA)
Not yet recruiting

Study of Antibody for Methamphetamine Outpatient Therapy

Wed, 08 Nov 2017 12:00:00 EST

Conditions:   Methamphetamine-dependence;   Methamphetamine Abuse
Interventions:   Drug: Placebo;   Drug: IXT-m200
Sponsors:   InterveXion Therapeutics, LLC;   National Institute on Drug Abuse (NIDA)

Using Mobile Technology to Better Understand and Measure Self-regulation

Fri, 24 Nov 2017 12:00:00 EST

Conditions:   Self-regulation;   Binge Eating;   Smoking
Intervention:   Behavioral: Laddr
Sponsors:   Dartmouth-Hitchcock Medical Center;   National Institutes of Health (NIH);   National Institute on Drug Abuse (NIDA);   University of Memphis;   Ohio State University

ATN 151 Work-to-Prevent: Employment as HIV Prevention

Wed, 18 Oct 2017 12:00:00 EDT

Condition:   HIV Prevention
Intervention:   Behavioral: Employment Intervention
Sponsors:   University of North Carolina, Chapel Hill;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH)

Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma

Fri, 11 Aug 2017 12:00:00 EDT

Condition:   Glioblastoma Multiforme (Grade IV) of Cerebellum
Interventions:   Drug: Cannabis;   Drug: Temozolomide;   Radiation: Radiation Therapy
Sponsor:   New York State Psychiatric Institute

MEMO-Medical Marijuana and Opioids Study

Thu, 31 Aug 2017 12:00:00 EDT

Conditions:   Opioid Use;   Marijuana;   Chronic Pain;   HIV/AIDS
Sponsors:   Albert Einstein College of Medicine, Inc.;   Fordham University;   Columbia University;   National Institute on Drug Abuse (NIDA)
Not yet recruiting

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075

Tue, 15 Aug 2017 12:00:00 EDT

Condition:   Opioid Use Disorder
Interventions:   Drug: buprenorphine/naloxone;   Other: Pharmacist-administered buprenorphine/naloxone maintenance care
Sponsors:   Duke University;   National Institute on Drug Abuse (NIDA);   The EMMES Corporation

The Impact of E-liquid Nicotine Content on Reinforcement in Current Smokers

Wed, 14 Jun 2017 12:00:00 EDT

Condition:   Tobacco Use
Intervention:   Behavioral: E-liquid sampling and preference assessment
Sponsors:   Wake Forest University Health Sciences;   National Institute on Drug Abuse (NIDA)
Not yet recruiting

REN-Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors

Wed, 14 Jun 2017 12:00:00 EDT

Condition:   Smoking
Interventions:   Other: NNC Spectrum Cigarette;   Other: VLNC Spectrum Cigarette;   Other: Moderate nicotine level e-liquid;   Other: Low/O nicotine level e-liquid;   Other: Cigarette flavors;   Other: Cigarette and non-cigarette e-liquid flavors
Sponsors:   Wake Forest University Health Sciences;   University of Pennsylvania;   National Institute on Drug Abuse (NIDA)
Not yet recruiting

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Tue, 02 May 2017 12:00:00 EDT

Conditions:   HIV/AIDS;   Hepatitis C;   Substance Use Disorders;   Opioid-use Disorder
Interventions:   Other: Information Control;   Other: HIV and HCV Testing Practice Coaching Intervention;   Other: HIV Testing Practice Coaching Intervention
Sponsors:   Columbia University;   National Institute on Drug Abuse (NIDA);   Weill Medical College of Cornell University;   University of Miami;   Johns Hopkins University;   Boston Medical Center;   Medical University of South Carolina;   Research Foundation for Mental Hygiene, Inc.;   San Francisco Department of Public Health;   Aspire Health Partners

Onsite Buprenorphine Treatment at Syringe Exchange Programs

Fri, 12 May 2017 12:00:00 EDT

Condition:   Opiate Addiction
Interventions:   Behavioral: Onsite treatment;   Behavioral: Enhanced referral;   Drug: Buprenorphine
Sponsors:   Montefiore Medical Center;   National Institute on Drug Abuse (NIDA)
Not yet recruiting

Exploring Gut-Brain and Brain-Gut Interactions in Alcohol Use Disorder Via Microbiota Investigations: A Pilot Study

Mon, 15 May 2017 12:00:00 EDT

Condition:   Alcoholism
Sponsors:   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institute on Drug Abuse (NIDA);   The Peter G. Dodge Foundation (PGDF)

Text Message Support to Prevent Smoking Relapse

Fri, 18 Nov 2016 12:00:00 EST

Condition:   Tobacco Use Disorder
Interventions:   Behavioral: Text Message Craving Program;   Behavioral: Self-Help Manual Plus Control Texts
Sponsors:   Miami University;   National Institute on Drug Abuse (NIDA);   University of Cincinnati
Not yet recruiting

BUPrenorphine Facilitated Access and Supportive Treatment --AIM 3

Fri, 16 Sep 2016 12:00:00 EDT

Condition:   Opioid-related Disorders
Interventions:   Behavioral: BUP_FAST;   Behavioral: Referral to treatment
Sponsors:   Montefiore Medical Center;   National Institute on Drug Abuse (NIDA)

Effects of a New Behavioral Intervention on Alcohol Craving and Drinking

Wed, 13 Jul 2016 12:00:00 EDT

Conditions:   Alcohol Drinking;   Alcohol Drinking Related Problems
Interventions:   Behavioral: Retrieval-extinction;   Behavioral: Extinction;   Behavioral: Retrieval
Sponsor:   National Institute on Drug Abuse (NIDA)

Impact of Smoking and Its Cessation on Systemic and Airway Immune Activation

Mon, 18 Jul 2016 12:00:00 EDT

Conditions:   HIV;   Smoking
Interventions:   Behavioral: Counseling;   Drug: Smoking Cessation drugs;   Procedure: Bronchoscopy;   Procedure: Blood Draw;   Behavioral: Questionnaires
Sponsors:   Boston Medical Center;   National Institute on Drug Abuse (NIDA)

Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)

Thu, 09 Jun 2016 12:00:00 EDT

Condition:   Contraception
Intervention:   Behavioral: Intervention
Sponsors:   Denver Health and Hospital Authority;   National Institute on Drug Abuse (NIDA)

Mindfulness Meditation for the Treatment of Women With Comorbid PTSD and SUD

Thu, 28 Apr 2016 12:00:00 EDT

Conditions:   Stress Disorders, Post-Traumatic;   Substance-Related Disorders
Intervention:   Behavioral: Mindfulness Based Relapse Prevention (MBRP)
Sponsors:   Medical University of South Carolina;   National Institute on Drug Abuse (NIDA);   National Institutes of Health (NIH)

Community Supported Risk Reduction for Syringe Exchange Participants

Wed, 13 Jan 2016 12:00:00 EST

Conditions:   Substance Use Disorders;   Risk Reduction
Intervention:   Behavioral: Risk Reduction Group
Sponsors:   Johns Hopkins University;   National Institute on Drug Abuse (NIDA)

Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence

Mon, 21 Dec 2015 12:00:00 EST

Condition:   Nicotine Dependence
Intervention:   Device: mSMART
Sponsors:   Duke University;   Intelligent Automation, Inc.;   National Institute on Drug Abuse (NIDA)

Evaluation of EBT With Young, Substance Abusing Homeless Mothers

Fri, 16 Oct 2015 12:00:00 EDT

Condition:   Substance Use
Interventions:   Behavioral: Ecologically Based Therapy;   Behavioral: Housing Only;   Behavioral: Treatment as Usual
Sponsors:   Ohio State University;   National Institute on Drug Abuse (NIDA)

Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study

Wed, 30 Sep 2015 12:00:00 EDT

Conditions:   Cocaine Dependence;   Cocaine Addiction;   Cocaine Abuse;   Cocaine-Related Disorders
Interventions:   Drug: Clavulanic acid;   Drug: Intravenous cocaine;   Drug: Placebo
Sponsors:   Temple University;   National Institute on Drug Abuse (NIDA);   University of Pennsylvania

Improving Treatment Outcomes for Prescription Opioid Dependence

Mon, 07 Sep 2015 12:00:00 EDT

Condition:   Drug Dependence
Interventions:   Drug: Gabapentin;   Drug: Buprenorphine;   Drug: Clonidine;   Drug: Naltrexone (oral);   Drug: Naltrexone (depot);   Drug: Placebo
Sponsors:   University of Arkansas;   National Institute on Drug Abuse (NIDA)

Drug Interaction and Self Administration Studies of Compounds for Cocaine Use Disorder

Wed, 02 Sep 2015 12:00:00 EDT

Condition:   Cocaine Use Disorder
Interventions:   Drug: Lorcaserin;   Drug: Cocaine Intravenous (IV);   Drug: Placebo comparator
Sponsors:   Virginia Commonwealth University;   National Institute on Drug Abuse (NIDA)

Buprenorphine Group Medical Visits in Primary Care

Tue, 18 Aug 2015 12:00:00 EDT

Condition:   Opioid-Related Disorders
Interventions:   Behavioral: G-BMT;   Behavioral: Treatment as usual;   Drug: Buprenorphine
Sponsors:   Montefiore Medical Center;   National Institute on Drug Abuse (NIDA)

Addressing Post Cessation Weight Gain

Thu, 09 Apr 2015 12:00:00 EDT

Conditions:   Obesity;   Smoking Cessation
Interventions:   Drug: lorcaserin;   Drug: Varenicline;   Drug: Placebo
Sponsors:   Mayo Clinic;   National Institute on Drug Abuse (NIDA)

SteadyRx: Smartphone ART Adherence Intervention for Drug Users

Tue, 16 Dec 2014 12:00:00 EST

Conditions:   HIV;   Medication Adherence
Intervention:   Behavioral: SteadyRx
Sponsors:   Johns Hopkins University;   National Institute on Drug Abuse (NIDA);   Western Michigan University

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry

Tue, 03 Dec 2013 12:00:00 EST

Conditions:   Heroin Dependence;   Opioid-Related Disorders
Intervention:   Drug: Extended-Release Naltrexone
Sponsors:   New York University School of Medicine;   National Institute on Drug Abuse (NIDA);   Friends Research Institute, Inc.;   University of California, Los Angeles

Smoking Cessation for People Living With HIV/AIDS

Fri, 18 Oct 2013 12:00:00 EDT

Conditions:   HIV;   AIDS;   Nicotine Dependence
Interventions:   Drug: Bupropion;   Behavioral: Brief Counseling;   Behavioral: High-magnitude prize contingency management;   Behavioral: Monitored support to quit smoking;   Behavioral: No additional treatment;   Behavioral: Prize contingency management for abstinence;   Behavioral: Low intensity prize contingency management
Sponsors:   Wayne State University;   National Institute on Drug Abuse (NIDA)

Nicotine Withdrawal Symptoms and Smoking Relapse

Wed, 18 Jan 2012 12:00:00 EST

Condition:   Nicotine Dependence
Sponsor:   National Institute on Drug Abuse (NIDA)

Characterization of Phenotypic and Genotypic Regressors for Imaging

Tue, 22 Jun 2010 12:00:00 EDT

Condition:   Regressors
Sponsor:   National Institute on Drug Abuse (NIDA)

Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

Mon, 21 Dec 2009 12:00:00 EST

Conditions:   Drug Abuse;   Nicotine Dependence
Sponsor:   National Institute on Drug Abuse (NIDA)

Cognitive Task Development and Implementation for Functional MRI Studies

Mon, 21 Dec 2009 12:00:00 EST

Condition:   Drug Abuse
Sponsor:   National Institute on Drug Abuse (NIDA)